Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||KLH conjugated synthetic peptide between 48-74 amino acids from the central region of human APITD1|
|Purification||Antigen affinity chromatography|
|Contains||0.09% sodium azide|
|Storage Conditions||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||1:10-1:50|
|Western Blot (WB)||1:1000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
This antibody is predicted to react with bovine based on sequence homology.
APITD1 was identified in the neuroblastoma tumour suppressor candidate region on chromosome 1p36. It contains a TFIID-31 domain, similar to that found in TATA box-binding protein-associated factor, TAF(II)31, which is required for p53-mediated transcription activation. This gene was expressed at very low levels in neuroblastoma tumours, and was shown to reduce cell growth in neuroblastoma cells, suggesting that it may have a role in a cell death pathway.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
apoptosis-inducing TAF9-like domain-containing protein 1; apoptosis-inducing TAF9-like domain-containing protein 1 homolog; CENPS; centromere protein S; FAAP16; FANCM-interacting histone fold protein 1; MHF1; ortholog of human apoptosis-inducing, TAF9-like domain 1 APITD1
2610040C18Rik; 2810407L01Rik; APITD1; CENP-S; CENPS; FAAP16; MHF1